OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Halozyme Therapeutics/  US40637H1095  /

IEX
31/05/2024  21:59:55 Chg. +0.98 Volume Bid- Ask- High Low
44.33USD +2.25% 32,127
Turnover: 1.42 mill.		 -Bid Size: - -Ask Size: - 44.52 43.40

Business description

-
 

Management board & Supervisory board

CEO
Helen Torley
Management board
Nicole LaBrosse, Mark Snyder, Michael J. LaBarre, Chris Wahl, Cortney Caudill, Tram Bui, Gary Grote, Amy Fox, Steve Knowles, Christopher Bryant, Kristin Schwartzbauer
Supervisory board
Jeffrey W. Henderson, Jean-Pierre Bizzari, Barbara Duncan, Matthew L. Posard, Connie L. Matsui, Moni Miyashita, Bernadette Connaughton, Helen Torley
 

Company data

Name: Halozyme Therapeutics Inc.
Address: -,-
Phone: -
Fax: -
E-mail: -
Internet: -
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: -
Free Float: -
IPO date: -

Investor relations

Name: -
IR phone: -
IR Fax: -
IR e-mail: -

Main Shareholders